Minoxidil, a potent peripheral vasodilator, was originally approved by the FDA in 1979 as an oral agent for patients with severe refractory hypertension with antihypertensive dosing ranging from ...

A total of 332 patients entered the study and 277 patients were randomised and treated, 137 with FP250µg twice daily via Diskus TM inhaler ... each treatment [fluticasone propionate (FP) 250µg ...

Objective: To evaluate the efficacy and tolerability of two inhaled corticosteroid treatment regimens, fluticasone propionate (FP) delivered from a Diskus TM inhaler and budesonide delivered from ...